CompletedPhase 4ACTRN12611000631909

Vitamin D Deficiency in Human Immunodeficiency Virus

The effect of Cholecalciferol and dietary advice on Vitamin D levels in participants with Human Immunodeficiency Virus Infection


Sponsor

The Alfred Hospital Research Trust

Enrollment

40 participants

Start Date

Jul 2, 2009

Study Type

Interventional

Conditions

Summary

The primary purpose of the study is to measure the prevalence of vitamin D deficiency in the HIV population at the Alfred Hospital, and then to evaluate the effectiveness of vitamin D supplementation in this population.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This trial looks at vitamin D deficiency in adults living with HIV. Researchers are studying people over 18 who have both HIV and low vitamin D levels (below 50 nmol/l) to better understand and address this common nutritional gap in HIV patients.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of v

Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of vitamin D in diet plus advice regarding safe levels of sunlight exposure


Locations(1)

The Alfred - Prahran

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000631909


Related Trials